Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Visiopharm

Visiopharm
2001 FOUNDED
PRIVATE STATUS
41-50 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
1 INVESTORS
Description

Provider of image analysis and stereology software. The company provides software for quantitative microscopy within the life science industry. Its software combines the strengths of image analysis and stereology into one software platform, which is designed to operate on a wide variety of microscopes and virtual slide microscopes.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Social/Platform Software
Other Industries
Other Software
Primary Office
  • Agern Allé 24
  • 2970 Hørsholm
  • Denmark

+45 88 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Visiopharm’s full profile, request a free trial.

Visiopharm Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 05-Oct-2007 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Visiopharm Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genedata Venture Capital-Backed Basel, Switzerland 000 000000 - 000
000000 Formerly VC-backed Belfast, United Kingdom 00 00.00 000000&0 00.00
To view this company’s complete list of competitors, request access »

Visiopharm Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 0000000 01-Dec-2016 000000000000000000 Other Devices and Supplies 0000000 0000000 00.0
Digital Pathology Consultants 08-Dec-2012 Merger/Acquisition Consulting Services (B2B) 0000000 0000000 00.0
To view this company’s complete investment and acquisition history, request access »

Visiopharm Subsidiaries (1)

Company Name Industry Location Founded
000 0000000 Other Devices and Supplies Lund, Sweden 0000
To view this company’s complete subsidiary history, request access »

Visiopharm Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
NorthCap Partners Venture Capital Minority 000 0000 000000 0

Visiopharm Executive Team (8)

Name Title Board
Seat
Contact
Info
Michael Grunkin Ph.D Co-Founder, Chief Executive Officer, managing Director & Board Member
Kristian Dalhof Nielsen Chief Financial Officer
Johan Hansen Co-Founder, Chief Technical Officer & Board Member
Helle Fisker Chief Marketing Officer
Andreas Schønau Chief Scientific Officer
You’re viewing 5 of 8 executives. Get the full list »

Visiopharm Board Members (6)

Name Representing Role Since Contact
Info
Henrik Stender Ph.D Self Board Member 000 0000
Johan Hansen Visiopharm Co-Founder, Chief Technical Officer & Board Member 000 0000
Michael Grunkin Ph.D Visiopharm Co-Founder, Chief Executive Officer, managing Director & Board Member 000 0000
Patrik Dahlen Ph.D Self Chairman 000 0000
Susanne Høiberg Self Director 000 0000
You’re viewing 5 of 6 board members. Get the full list »